Prof. Gordon B. Mills MD Anderson Cancer Center, USA

Gordon B. Mills, MD, PhD, was recruited to The University of Texas M. D. Anderson Cancer Center (MDACC) in 1994, where he holds the rank of Professor with joint appointments in Systems Biology, Breast Medical Oncology and Immunology, and serves as chairman of the Department of Systems Biology. Dr. Mills... read moreis Director of the Kleberg Center for Molecular Markers and Director for the South Campus Research Building II. Dr. Mills is also co-Director of the Sheikh Zayed bin Sultan Al Nahyan Institute for Personalized Cancer Therapy. The Center and the Institute are responsible for developing and implementing personalized molecular medicine at MDACC. Dr. Mills has published extensively on the molecular analysis of cancer and currently serves as principal investigator or project investigator on many national peer review grants including Stand Up To Cancer, NIH/NCI SPOREs U24 and PPGs, Department of Defense, CPRIT and Komen Foundation grants, and is a collaborator on multiple other national grants. He has recently been awarded the Komen Brinker award for Scientific Excellence and the Stand up to Cancer Laura Ziskin Prize for mentoring. Dr. Mills has published more than 700 papers; holds more than 20 patents related to novel technologies and molecular markers and has co-founded an early diagnostics company. He currently sits on the scientific advisory boards of multiple companies and venture capital groups.